×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| SUVEN LIFE SCIENCES LTD. | 32.4 | -391.17 | 16.1 | -1.79 | 2,565 | |
| Krsnaa Diagnostics Limited | 1837.49 | 194.15 | 1745.12 | 5.88 | 2350 | 31.1 |
| Shalby Limited | 2269.15 | 208.58 | 2206.4 | 1.94 | 2203 | 70.3 |
Suven Life Sciences Ltd., with Security Code 530239, is a leading player in the Healthcare Research- Analytics & Technology industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.5 | 4.3 | 3.0 | 2.6 | 3.7 | 3.0 | 2.4 | 2.3 | 1.0 | 2.5 |
| Expenses | 10.6 | 11.8 | 10.1 | 8.7 | 10.6 | 11.1 | 11.6 | 9.3 | 11.1 | 16.2 |
| Operating Profit | -7.1 | -7.5 | -7.1 | -6.1 | -6.8 | -8.1 | -9.2 | -6.9 | -10.1 | -13.6 |
| OPM % | -199.63% | -169.82% | -236.61% | -234.62% | -178.96% | -263.89% | -375.28% | -288.05% | -1002.78% | -529.97% |
| Other Income | 6.4 | 0.2 | 2.2 | 5.6 | 5.6 | 12.6 | 6.1 | 4.3 | 3.9 | 4.0 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 1.6 | 1.6 | 1.7 | 1.7 | 1.7 | 1.7 | 1.6 | 1.5 | 1.5 | 1.5 |
| Profit before tax | -8.3 | -8.9 | -6.6 | -2.3 | -2.9 | -4.7 | -4.8 | -4.1 | -7.7 | -11.1 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -24.3% | 0% | 0% |
| Net Profit | -2.3 | -8.9 | -6.6 | -2.2 | -2.9 | 2.8 | -4.8 | -3.1 | -7.7 | -11.1 |
| EPS in Rs | -0.16 | -0.61 | -0.35 | -0.05 | -0.13 | 0.13 | -0.22 | -0.14 | -0.35 | -0.51 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.4 | 3.0 | 2.6 | 3.8 | 3.1 | 2.5 | 2.4 | 1.0 | 2.6 | 1.6 |
| Expenses | 26.1 | 54.6 | 34.1 | 31.8 | 26.6 | 48.6 | 32.7 | 31.6 | 54.8 | 40.8 |
| Operating Profit | -21.7 | -51.6 | -31.5 | -28.0 | -23.5 | -46.2 | -30.3 | -30.5 | -52.2 | -39.2 |
| OPM % | -494.7% | -1718.5% | -1207.2% | -737.8% | -768.3% | -1884.5% | -1269.8% | -3036.2% | -2029% | -2435.4% |
| Other Income | 0.2 | 2.2 | 5.6 | 5.6 | 12.6 | 6.1 | 4.3 | 4.0 | 4.0 | 1.6 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 1.6 | 1.7 | 1.7 | 1.7 | 1.7 | 1.6 | 1.5 | 1.5 | 1.5 | 1.5 |
| Profit before tax | -23.2 | -51.1 | -27.6 | -24.1 | -20.1 | -41.8 | -27.5 | -28.0 | -49.6 | -39.1 |
| Tax % | -0% | -0% | -0% | -0% | -0% | -0% | -3.6% | -0% | -0% | -0% |
| Net Profit | -23.2 | -51.1 | -27.6 | -24.1 | -12.7 | -41.8 | -26.5 | -28.0 | -49.6 | -39.1 |
| EPS in Rs | -1 | -2 | -1 | -1 | 0 | -1 | -1 | -1 | -2 | -1 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -31% |
| 5 Years: | -47% |
| 3 Years: | -5% |
| TTM: | -36% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 4% |
| TTM: | -141% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 18% |
| 3 Years: | 17% |
| 1 Year: | 11% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -47% |
| 3 Years: | -5% |
| TTM: | -36% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -28% |
| TTM: | -26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 18% |
| 3 Years: | 17% |
| 1 Year: | 11% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|